{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:08:35Z","timestamp":1791464915846,"version":"4.3.4"},"reference-count":54,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The no-reflow phenomenon following primary percutaneous coronary intervention (PPCI) in acute ST-elevation myocardial infarction (STEMI) patients is a predictor of unfavorable prognosis. Patients with no-reflow have many complications during admission, and it is considered a marker of short-term mortality. The current research emphasizes the circumstances of the incidence and complications of the no-reflow phenomenon in STEMI patients, including in-hospital mortality. In this case-control study, conducted over two and a half years, there were enrolled 656 patients diagnosed with STEMI and reperfused through PPCI. Several patients (n = 96) developed an interventional type of no-reflow phenomenon. One third of the patients with a no-reflow phenomenon suffered complications during admission, and 14 succumbed. Regarding complications, the majority consisted of arrhythmias (21.68%) and cardiogenic shock (16.67%). The anterior localization of STEMI and the left anterior descending artery (LAD) as a culprit lesion were associated with the highest number of complications during hospitalization. At the same time, the time interval &gt;12 h from the onset of the typical symptoms of myocardial infarction (MI) until revascularization, as well as multiple stents implantations during PPCI, correlated with an increased incidence of short-term complications. The no-reflow phenomenon in patients with STEMI was associated with an unfavorable short-term prognosis.<\/jats:p>","DOI":"10.3390\/jcm9092956","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:11:32Z","timestamp":1600031492000},"page":"2956","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["No-Reflow after PPCI\u2014A Predictor of Short-Term Outcomes in STEMI Patients"],"prefix":"10.3390","volume":"9","author":[{"given":"Larisa Renata","family":"Pantea-Ro\u0219an","sequence":"first","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital of Oradea, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad Alin","family":"Pantea","sequence":"additional","affiliation":[{"name":"Department of Morphological Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3236-1292","authenticated-orcid":false,"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-6592","authenticated-orcid":false,"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-9601","authenticated-orcid":false,"given":"Cosmin Mihai","family":"Vesa","sequence":"additional","affiliation":[{"name":"Clinical County Emergency Hospital of Oradea, 410169 Oradea, Romania"},{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bustea","sequence":"additional","affiliation":[{"name":"Clinical County Emergency Hospital of Oradea, 410169 Oradea, Romania"},{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Dumitru","family":"Moleriu","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Faculty of Mathematics and Computer Science, West University of Timisoara, 300223 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-9076","authenticated-orcid":false,"given":"Marius","family":"Rus","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital of Oradea, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Ioachim","family":"Popescu","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital of Oradea, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-8872","authenticated-orcid":false,"given":"Vladiana","family":"Turi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 30041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-260X","authenticated-orcid":false,"given":"Camelia Cristina","family":"Diaconu","sequence":"additional","affiliation":[{"name":"Department 5, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Internal Medicine Department, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2014.06.008","article-title":"Pharmacological Approaches to Coronary Microvascular Dysfunction","volume":"144","author":"Guarini","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jamainternmed.2014.3328","article-title":"How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients with Stable Angina: A Qualitative Analysis","volume":"174","author":"Goff","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","article-title":"Microvascular Obstruction and the No-Reflow Phenomenon after Percutaneous Coronary Intervention","volume":"117","author":"Jaffe","year":"2008","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcha.2015.11.002","article-title":"Predictors and Outcome of No-Reflow Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction","volume":"10","author":"Mazhar","year":"2015","journal-title":"IJC Heart Vasc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","article-title":"American College of Cardiology National Cardiovascular Data Registry. Incidence and Outcomes of No-Reflow Phenomenon during Percutaneous Coronary Intervention among Patients with Acute Myocardial Infarction","volume":"111","author":"Harrison","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.ihj.2018.01.032","article-title":"The Predictors of No Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Meta-Analysis","volume":"70","author":"Fajar","year":"2018","journal-title":"Indian Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ccd.26698","article-title":"The Incidence of Slow Flow after Rotational Atherectomy of Calcified Coronary Arteries: A Randomized Study of Low Speed Versus High Speed","volume":"89","author":"Sakakura","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0","article-title":"Intracoronary Adenosine Administered during Percutaneous Intervention in Acute Myocardial Infarction and Reduction in the Incidence of \u201cNo Reflow\u201d Phenomenon","volume":"51","author":"Assali","year":"2000","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4070\/kcj.2016.46.4.490","article-title":"Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena Following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction","volume":"46","author":"Kim","year":"2016","journal-title":"Korean Circ. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCA.0000000000000726","article-title":"Predictors and Outcomes of No-Reflow Phenomenon in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","volume":"30","author":"Tasar","year":"2019","journal-title":"Coron. Artery Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mhj.2003.36","article-title":"No-reflow Is an Independent Predictor of Death and Myocardial Infarction After Percutaneous Coronary Intervention","volume":"145","author":"Resnic","year":"2003","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157340312803217148","article-title":"Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory","volume":"8","author":"Berg","year":"2012","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":"Angiographic No-Reflow Phenomenon as a Predictor of Adverse Long-Term Outcome in Patients Treated with Percutaneous Transluminal Coronary Angioplasty for First Acute Myocardial Infarction","volume":"36","author":"Morishima","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical Implications of the \u2018No Reflow\u2019 Phenomenon. A Predictor of Complications and Left Ventricular Remodeling in Reperfused Anterior Wall Myocardial Infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/j.hlc.2015.06.393","article-title":"Incidence and outcomes of the no-reflow phenomenon during percutaneous coronary intervention: Insights from the CADOSA registry","volume":"24","author":"Ooi","year":"2015","journal-title":"Heart Lung Circ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ihj.2016.04.006","article-title":"No Reflow Phenomenon in Percutaneous Coronary Interventions in ST-segment Elevation Myocardial Infarction","volume":"68","author":"Gupta","year":"2016","journal-title":"Indian Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4244\/EIJ-D-17-00269","article-title":"Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): A Multicentre Australian Registry","volume":"14","author":"Papapostolou","year":"2018","journal-title":"EuroIntervention"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"World Medical Association declaration of Helsinki (1997). Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 277, 925\u2013926.","DOI":"10.1001\/jama.277.11.925"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_20","unstructured":"Lee, A.S., William, S.G., and John, J. (2020, June 08). TIMI Grade Flow, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482412\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2013.01.048","article-title":"Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Cardiac Magnetic Resonance Substudy of the AIDA STEMI Trial","volume":"61","author":"Eitel","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","article-title":"Angiographic Assessment of Myocardial Reperfusion in Patients Treated with Primary Angioplasty for Acute Myocardial Infarction","volume":"97","author":"Hof","year":"1998","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on Myocardial Revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed By: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15420\/icr.2013.8.2.73","article-title":"Evidence-based Management of Cardiogenic Shock after Acute Myocardial Infarction","volume":"8","author":"Werdan","year":"2013","journal-title":"Interv. Cardiol."},{"key":"ref_26","first-page":"30","article-title":"Predictors and Prognosis of No-Reflow during Primary Percutaneous Coronary Intervention","volume":"32","author":"Jayaprasad","year":"2018","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","first-page":"522","article-title":"Predictors of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention","volume":"52","year":"2014","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0735-1097(01)01405-X","article-title":"Predictive Factors for Development of the No-Reflow Phenomenon in Patients with Reperfused Anterior Wall Acute Myocardial Infarction","volume":"38","author":"Iwakura","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCINTERVENTIONS.109.896225","article-title":"Predictive Factors and Impact of No Reflow after Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction","volume":"3","author":"Ndrepepa","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ijcard.2016.07.209","article-title":"The No-Reflow Phenomenon in the Young and in the Elderly","volume":"222","author":"Cenko","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_32","unstructured":"Michael, M., and Breall, J.A. (2020, September 03). No-Reflow Phenomenon during PCI. Available online: https:\/\/www.dicardiology.com\/article\/no-reflow-phenomenon-during-pci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1536\/ihj.14-057","article-title":"Etiology and Clinical Implications of Microvascular Dysfunction in Patients with Acute Myocardial Infarction","volume":"55","author":"Ito","year":"2014","journal-title":"Int. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MCA.0000000000000108","article-title":"The Impact of No-Reflow Phenomena after Primary Percutaneous Coronary Intervention: A Time-Dependent Analysis of Mortality","volume":"25","author":"Choo","year":"2014","journal-title":"Coron. Artery Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7775\/rac.es.v81.i3.1423","article-title":"Clinical Predictors of No-Reflow in Percutaneous Coronary Intervention for Acute Myocardial Infarction","volume":"81","author":"Gagliardi","year":"2013","journal-title":"Rev. Argent. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/heart.85.6.705","article-title":"Acute Myocardial Infarction: Primary Angioplasty","volume":"85","author":"Zijlstra","year":"2001","journal-title":"Heart"},{"key":"ref_37","first-page":"39","article-title":"No Reflow Phenomenon in Coronary Heart Disease","volume":"37","author":"Ito","year":"2001","journal-title":"J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vesa, C.M., Popa, L., Popa, A.R., Rus, M., Zaha, A.A., Bungau, S., Tit, D.M., Corb Aron, R.A., and Zaha, D.C. (2020). Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics, 10.","DOI":"10.3390\/diagnostics10050314"},{"key":"ref_39","first-page":"419","article-title":"The Role of Increased Plasmatic Renin Level in the Pathogenesis of Arterial Hypertension in Young Adults","volume":"52","author":"Stoicescu","year":"2011","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_40","first-page":"133","article-title":"Acute kidney injury incidence and models for mortality prediction in acute coronary syndromes","volume":"113","author":"Moisi","year":"2020","journal-title":"Rom. J. Mil. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Moisi, M.I., Rus, M., Bungau, S., Zaha, D.C., Uivarosan, D., Fratila, O., Tit, D.M., Endres, L., Nistor-Cseppento, D.C., and Popescu, M.I. (2020). Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics. Medicina, 56.","DOI":"10.3390\/medicina56030118"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2174\/1381612824666180702112536","article-title":"Coronary No-Reflow Phenomenon in Clinical Practice","volume":"24","author":"Scarpone","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jacc.2007.10.047","article-title":"Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention: The Drug Elution and Distal Protection in ST-elevation Myocardial Infarction (DEDICATION) Trial","volume":"51","author":"Kelbaek","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","first-page":"121","article-title":"The Diagnosis and Treatment of the No-Reflow Phenomenon in Patients with Myocardial Infarction Undergoing Percutaneous Coronary Intervention","volume":"13","author":"Ramjane","year":"2008","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCINTERVENTIONS.108.794578","article-title":"Clinical Outcome after Primary Percutaneous Coronary Intervention with Drug-Eluting and Bare Metal Stents in Patients with ST-segment Elevation Myocardial Infarction","volume":"1","author":"Jensen","year":"2008","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.carrev.2016.08.013","article-title":"Association of Endothelial Dysfunction and No-Reflow during Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction","volume":"17","author":"Levi","year":"2016","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_47","first-page":"215","article-title":"Management of No-Reflow Phenomenon in the Catheterization Laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"JACC"},{"key":"ref_48","first-page":"294065","article-title":"Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction","volume":"2014","author":"Hamza","year":"2014","journal-title":"Int. J. Vasc. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.89.6.2514","article-title":"Incidence and treatment of \u2018no-reflow\u2019 after percutaneous coronary intervention","volume":"89","author":"Piana","year":"1994","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10557-019-06901-0","article-title":"Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon","volume":"33","author":"Allencherril","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5603\/CJ.2012.0009","article-title":"ST-segment Resolution After Primary Percutaneous Coronary Intervention in Patients with Acute ST-segment Elevation Myocardial Infarction","volume":"19","author":"Ndrepepa","year":"2012","journal-title":"Cardiol. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/AJR.07.2518","article-title":"No-reflow Phenomenon in Cardiac MRI: Diagnosis and Clinical Implications","volume":"191","author":"Pineda","year":"2008","journal-title":"Am. J. Roentgenol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10741-006-0231-0","article-title":"Imaging Microvascular Obstruction and Its Clinical Significance Following Acute Myocardial Infarction","volume":"11","author":"Luo","year":"2006","journal-title":"Heart Fail. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI Patients","volume":"7","author":"Magro","year":"2014","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2956\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:09:30Z","timestamp":1760177370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["jcm9092956"],"URL":"https:\/\/doi.org\/10.3390\/jcm9092956","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]}}}